Page 13 - 南京医科大学学报自然科学版
P. 13

第42卷第1期       朱晓晗,刘晓蕊,李       琳,等. 利用CRISPR/Cas9技术高效构建巴马小型猪F9基因敲除细胞系[J].
                  2022年1月                     南京医科大学学报(自然科学版),2022,42(01):001-007                       · 7  ·


                下来构建血友病乙巴马小型猪模型提供了重要的                            [11] 曾华沙,姚      俊,王红顺,等. 人/猪OSBPL2同源性比较
                原材料。                                                   及猪 PFFs 靶基因敲除细胞系的建立[J]. 南京医科大
                                                                       学学报(自然科学版),2018,38(2):149-154
               [参考文献]
                                                                 [12] ZHANG R,WANG Y,CHEN L,et al. Reducing immuno⁃
               [1] LJUNG R. How I manage patients with inherited haemo⁃
                                                                       reactivity of porcine bioprosthetic heart valves by geneti⁃
                    philia A and B and factor inhibitors[J]. Br J Haematol,
                                                                       cally ⁃ deleting three major glycan antigens,GGTA1/β
                    2018,180(4):501-510
                                                                       4GalNT2/CMAH[J]. Acta Biomater,2018,72:196-205
               [2] STOOF S,KERSSEBOOM R,DE VRIES F,et al. Hemo⁃
                                                                 [13] QU Y,NIE X,YANG Z,et al. The prevalence of hemo⁃
                    philia B in a female with intellectual disability caused by
                                                                       philia in mainland China:a systematic review and meta⁃
                    a deletion of Xq26.3q28 encompassing the F9[J]. Mol
                                                                       analysis[J]. Southeast Asian J Trop Med Public Health,
                    Genet Genomic Med,2018,6(6):1220-1224
                                                                       2014,45(2):455-466
               [3] DOLAN G,BENSON G,DUFFY A,et al. Haemophilia B:
                                                                 [14] SHARMA A,EASOW M M,SRIGANESH V,et al. Gene
                    where are we now and what does the future hold?[J].
                                                                       therapy for haemophilia[J]. Cochrane Database Syst Rev,
                    Blood Rev,2018,32(1):52-60
                                                                       2016,12(12):CD010822
               [4] GOODEVE A C. Hemophilia B:molecular pathogenesis
                                                                 [15] WANG D,WANG K,CAI Y. An overview of development
                    and mutation analysis[J]. J Thromb Haemost,2015,13
                                                                       in gene therapeutics in China[J]. Gene Ther,2020,27(7/
                    (7):1184-1195
                                                                       8):338-348
               [5] 王朝荣,余自强,孙         玲,等. 40 例血友病乙患者的基
                                                                 [16] MONAHAN P E,SAMULSKI R J,TAZELAAR J,et al.
                    因分析及发病机制研究[J].中国实验血液学杂志,
                                                                       Direct intramuscular injection with recombinant AAV
                    2013,21(4):963-968
                                                                       vectors results in sustained expression in a dog model of
               [6] GAO W,XU Y,LIU H,et al. Characterization of missense
                                                                       hemophilia[J]. Gene Ther,1998,5(1):40-49
                    mutations in the signal peptide and propeptide of FIX in
                    hemophilia B by a cell⁃based assay[J]. Blood Adv,2020,  [17] LIN H F,MAEDA N,SMITHIES O,et al. A coagulation
                                                                       factor IX⁃deficient mouse model for human hemophilia B
                    4(15):3659-3667
                                                                      [J]. Blood,1997,90(10):3962-3966
               [7] HUANG L,LI L,LIN S,et al. Molecular analysis of 76
                                                                 [18] CONG L,RAN F A,COX D,et al. Multiplex genome engi⁃
                    Chinese hemophilia B pedigrees and the identification of
                                                                       neering using CRISPR/Cas systems[J]. Science,2013,
                    10 novel mutations[J]. Mol Genet Genomic Med,2020,8
                                                                       339(6121):819-823
                    (11):e1482
               [8] 李    杰,闫振宇.血友病鼠模型的构建及研究进展[J].                 [19] CHEN F,WANG Y,YUAN Y,et al. Generation of B cell⁃
                                                                       deficient pigs by highly efficient CRISPR/Cas9⁃mediated
                    中国比较医学杂志,2019,29(6):141-146
                                                                       gene targeting[J]. J Genet Genomics,2015,42(8):437-
               [9] NICHOLS T C,HOUGH C,AGERSØ H,et al. Canine
                    models of inherited bleeding disorders in the develop⁃  444
                    ment of coagulation assays,novel protein replacement  [20] YAO J,ZENG H,ZHANG M,et al. OSBPL2⁃disrupted
                    and gene therapies[J]. J Thromb Haemost,2016,14(5):  pigs recapitulate dual features of human hearing loss and
                    894-905                                            hypercholesterolaemia[J]. J Genet Genomics,2019,46
               [10] WATSON A L,CARLSON D F,LARGAESPADA D,et           (8):379-387
                     al. Engineered swine models of cancer[J]. Front Genet,                 [收稿日期] 2020-10-26
                     2016,7:78                                                                  (本文编辑:蒋 莉)
   8   9   10   11   12   13   14   15   16   17   18